Satsuma Pharmaceuticals, Inc. Contracts & Agreements
38 Contracts & Agreements
- Business Finance (19 contracts)
- Business Operations (2)
- Human Resources (10)
- Mergers & Acquisitions (2)
- Real Estate (1)
- Uncategorized (4)
- Separation Agreement, dated March 31, 2023, by and between Detlef Albrecht and Satsuma Pharmaceuticals, Inc (Filed With SEC on May 11, 2023)
- Agreement and Plan of Merger, dated as of April 16, 2023, by and among Satsuma Pharmaceuticals, Inc., Shin Nippon Biomedical Laboratories, Ltd. and SNBL23 Merger Sub, Inc (Filed With SEC on April 17, 2023)
- Tender and Support Agreement, dated as of April 16, 2023, by among Shin Nippon Biomedical Laboratories, Ltd., SNBL23 Merger Sub, Inc. and certain stockholders and directors of the... (Filed With SEC on April 17, 2023)
- Form of Contingent Value Rights Agreement to be entered into between Shin Nippon Biomedical Laboratories, Ltd. and American Stock Transfer & Trust Company, LLC (Filed With SEC on April 17, 2023)
- At-The-Market Sales Agreement by and between the Registrant and Virtu Americas LLC, dated November 3, 2022 (Filed With SEC on November 3, 2022)
- Description of Capital Stock (Filed With SEC on March 15, 2022)
- Description of Capital Stock (Filed With SEC on March 25, 2021)
- Securities Purchase Agreement, dated February 26, 2021 (Filed With SEC on March 1, 2021)
- Registration Rights Agreement to be effective on March 3, 2021 (Filed With SEC on March 1, 2021)
- Fourth Amendment to the Amended and Restated Licensing Assignment Agreement, dated May 25, 2020, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 11, 2020)
- Description of Capital Stock (Filed With SEC on March 10, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 3, 2019)
- Form of Common Stock Certificate (Filed With SEC on September 3, 2019)
- 2019 Incentive Award Plan (Filed With SEC on September 3, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 3, 2019)
- Non-Employee Director Compensation Program (Filed With SEC on September 3, 2019)
- Form Change in Control and Severance Agreement (Filed With SEC on September 3, 2019)
- Amended and Restated Investors Rights Agreement, dated as of April 23, 2019, by and among Satsuma Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on August 16, 2019)
- Warrant by and between Satsuma Pharmaceuticals, Inc. and Silicon Valley Bank (Filed With SEC on August 16, 2019)
- Warrant by and between Satsuma Pharmaceuticals, Inc. and Life Science Loans II, LLC (Filed With SEC on August 16, 2019)
- Lease Agreement, dated January 9, 2018, by and between Satsuma Pharmaceuticals, Inc. and Kashiwa Fudosan America, Inc (Filed With SEC on August 16, 2019)
- Amended and Restated Licensing and Assignment Agreement, dated December 16, 2016, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical Laboratories, Ltd (Filed With SEC on August 16, 2019)
- First Amendment to Amended and Restated Licensing and Assignment Agreement, dated January 13, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 16, 2019)
- Second Amendment to Amended and Restated Licensing and Assignment Agreement, dated as of April 27, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 16, 2019)
- Third Amendment to the Amended and Restated Licensing and Assignment Agreement, dated October 6, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 16, 2019)
- Loan and Security Agreement, dated as of October 26, 2018, by and between Silicon Valley Bank and the Company (Filed With SEC on August 16, 2019)
- 2016 Equity Incentive Plan (Filed With SEC on August 16, 2019)
- Form of Stock Option Agreement under 2016 Equity Incentive Plan (Filed With SEC on August 16, 2019)
- 2019 Incentive Award Plan (Filed With SEC on August 16, 2019)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2019 Incentive Award Plan (Filed With SEC on August 16, 2019)
- Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2019 Incentive Award Plan (Filed With SEC on August 16, 2019)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Incentive Award Plan (Filed With SEC on August 16, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on August 16, 2019)
- Offer Letter, dated June 17, 2016, by and between Satsuma Pharmaceuticals, Inc. and John Kollins (Filed With SEC on August 16, 2019)
- First Amendment to Offer Letter, dated June 17, 2016, by and between Satsuma Pharmaceuticals, Inc. and John Kollins (Filed With SEC on August 16, 2019)
- Offer Letter, dated June 12, 2017, by and between Satsuma Pharmaceuticals, Inc. and Detlef Albrecht (Filed With SEC on August 16, 2019)
- Offer Letter, dated December 21, 2018, by and between Satsuma Pharmaceuticals, Inc. and Tom ONeil (Filed With SEC on August 16, 2019)
- Form of Indemnification Agreement for directors and officers (Filed With SEC on August 16, 2019)
